期刊
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY
卷 11, 期 1, 页码 33-38出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0b013e32834232b0
关键词
Ca2(+) signaling; CRAC channel; leukotrienes
资金
- Medical Research Council [G1000813] Funding Source: Medline
- MRC [G1000813] Funding Source: UKRI
- Medical Research Council [G1000813] Funding Source: researchfish
Purpose of review This review describes recent advances in our understanding of a major Ca2(+)-entry pathway, the Ca2(+) release-activated Ca2(+) (CRAC) channel, that is central to mast cell activation. Recent findings Animals in which the genes encoding the CRAC channel have been deleted have severely compromised mast cell function and reduced allergic responses. These functional consequences reflect the ability of CRAC channels to activate a range of spatially and temporally distinct responses in mast cells, which contribute to both rapid and slow phases of an allergic response. In addition, the cells can sustain their own activation through positive feedback cycles that involve CRAC channels. Drugs that inhibit CRAC channels are proving effective in treatment of allergic responses both in vitro and in animal models of asthma. Summary CRAC channels comprise a new therapeutic target for combating allergies including asthma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据